99
December 2, 2025 | 16:32

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW

The most recent episodes of BrainStorm can be found below.
Thank you Genentech, Eisai, and Lundbeck for your support of BrainStorm.

38
April 18, 2023 | 18:26

Sandra Bond Chapman Ph.D. and the Importance of Lifelong Brain Health - Part 1

Want to improve your brain’s performance? Why not? You’re using it anyway. Find out the latest from Dr. Sandi Bond Chapman, Founder and Chief Director

LISTEN NOW
37
April 4, 2023 | 23:33

Rebecca Chopp, Ph.D., and Her Unexpected Alzheimer’s Diagnosis (part 2)

Rebecca Chopp, Ph.D., built a life around a profession that prized the mind and then was unexpectedly diagnosed with Alzheimer's disease. Dr. Chopp, former Chancellor

LISTEN NOW
36
March 21, 2023 | 21:43

Rebecca Chopp, Ph.D., and Her Unexpected Alzheimer’s Diagnosis (part 1)

Rebecca Chopp, Ph.D., built a life around a profession that prized the mind and then was unexpectedly diagnosed with Alzheimer's disease. Hear how Dr. Chopp

LISTEN NOW
35
March 7, 2023 | 14:44

Dr. Rudy Tanzi -The Latest on Alzheimer's Drugs (part 2)

BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.
LISTEN NOW
34
February 21, 2023 | 20:06

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi

LISTEN NOW